Fig. 6From: Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challengesPBM promotes CCO activity and increases ATP production. Nitric oxide (NO) inhibits CCO activity by non-covalently binding with CCO. PBM treatment leads to the dissociation of NO from CCO, causing the increased activity of this complex and ATP productionBack to article page